pharmacovigilence

pharmacovigilence

the surveillance of a drug's performance, particularly of adverse reactions, after it has been released for marketing.
References in periodicals archive ?
Floyd will lead Dohmen's growing regulatory consulting practice as well as a portfolio of pre-commercial and post approval outsourced services in quality, regulatory, pharmacovigilence, REMS, medical affairs and medical communications.
This concept, which was originally defined for the drug pharmacovigilence in Western medicine (Alvarez-Requejo et al 1998), also has relevance to the domain of acupuncture.
Orlandi will be responsible for leading Clinical Development, Medical Affairs, Pharmacovigilence and Regulatory Affairs for the Company, including its Phase 3 clinical trial program for flurpiridaz F 18.
This is expected to include updating dossiers of selected products to help advance the emerging market strategy, investing in pharmacovigilence activities, and establishing a central database of regulatory information.
From 2008 to 2009, Keller served as vice president of regulatory affairs and pharmacovigilence for Medicis Pharmaceutical Corp.
Pinnacle provides a full range of services including regulatory, sales, marketing, distribution (including billings and collections), pharmacovigilence, product safety, market research and administrative services.
Regulators will raise the bar for innovation, drug approvals and pharmacovigilence.
More transparency over pharmacovigilence data and reporting;
The final section contains a chapter on clinical toxicology (acute overdose management), regulatory aspects of safety assessment, and pharmacovigilence.
Regulators will take a more proactive stance that will raise the bar for innovation and drug approvals and pharmacovigilence will be the story.
A potential excess of AEs is often defined as any product-event combination with a score exceeding the specified threshold (FDA Guidance for Industry: Good Pharmacovigilence Practices and Pharmacoepidemiologic Assessment, 2005).
Kamemoto will have primary responsibility for leading and directing all regulatory affairs and global pharmacovigilence activities.
Full browser ?